食品科学 ›› 2022, Vol. 43 ›› Issue (17): 147-155.doi: 10.7506/spkx1002-6630-20210720-228

• 营养卫生 • 上一篇    下一篇

牡蛎蛋白酶解物对小鼠慢性酒精性肝损伤的保护作用

蔡雯雯,葛小东,李娜,龚世禹,刘斌,陈福泉,曾峰   

  1. (1.闽台特色海洋食品加工及营养健康教育部工程研究中心,福建 福州 350002;2.福建农林大学食品科学学院,福建 福州 350002;3.集美大学海洋食品与生物工程学院,福建 厦门 361021)
  • 出版日期:2022-09-15 发布日期:2022-09-28
  • 基金资助:
    福建省科技重大专项(2020NZ012010);厦门海洋科技成果转化与产业化示范项目(18CYY026HJ13); 闽台特色海洋食品加工及营养健康教育部工程研究中心开放基金项目(2021ERC05)

Protective Effect of Oyster Protein Hydrolysate on Chronic Alcoholic Liver Injury in Mice

CAI Wenwen, GE Xiaodong, LI Na, GONG Shiyu, LIU Bin, CHEN Fuquan, ZENG Feng   

  1. (1. Engineering Research Centre of Fujian-Taiwan Special Marine Food Processing and Nutrition, Ministry of Education, Fuzhou 350002, China; 2. College of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China; 3. College of Ocean Food and Biological Engineering, Jimei University, Xiamen 361021, China)
  • Online:2022-09-15 Published:2022-09-28

摘要: 为探究牡蛎酶解物对小鼠慢性酒精性肝损伤的保护作用,采用牡蛎酶解物干预慢性酒精性肝损伤小鼠,测定小鼠血清中谷丙转氨酶(alaninetransaminase,ALT)活力、谷草转氨酶(aspartate aminotransferase,AST)活力、总胆汁酸(total bile acid,TBA)浓度以及肝脏指数和肝脏甘油三酯(triglyceride,TG)、丙二醛(malondialdehyde,MDA)含量等指标,观察肝脏的组织形态变化,分析肝脏相关基因mRNA转录水平以及肠道菌群结构的变化。结果表明,与模型组相比,高、低剂量牡蛎酶解物均显著降低了小鼠血清中ALT、AST活力和肝脏中TG、MDA含量(P<0.05、P<0.01),极显著提高了谷胱甘肽(glutathione,GSH)含量(P<0.01);牡蛎酶解物高剂量组的TBA浓度显著降低(P<0.05)。牡蛎酶解物高、低剂量都可改善酒精对小鼠肝脏造成的形态学损伤,与模型组相比,TLR4、TNF-α和NF-κB的转录水平均显著下调(P<0.05),在科水平上提高了小鼠肠道中Firmicutes的丰度,降低了Bacteroidetes的丰度,在属水平上提高了小鼠肠道中Lactobacillus和Alistipes丰度。结论:牡蛎酶解物对慢性酒精性肝损伤小鼠具有保护作用,其作用机制与降低AST、ALT活力和TG、MDA、TBA水平,提高GSH含量,下调TLR4、NF-κB和TNF-α基因转录水平以及肠道菌群结构变化有关。

关键词: 牡蛎酶解物;慢性酒精性肝损伤;保肝作用;肠道菌群

Abstract: This study aimed to explore the hepatoprotective effect of an enzymatic hydrolysate from oyster meat on chronic alcoholic liver injury in mice. After intervention with the hydrolysate, the serum levels of alaninetransaminase (ALT) activity, aspartate aminotransferase (AST) activity and total bile acid (TBA) concentration, liver index, and the contents of triglyceride (TG) and malondialdehyde (MDA) in the liver of mice with chronic alcoholic liver injury were measured, liver histomorphological changes were examined, and the mRNA transcription level of related genes in the liver and the changes of the gut microflora structure were analyzed. The results demonstrated that compared with the model group, the enzymatic hydrolysate at high and low doses significantly decreased the activity of serum ALT and AST and liver TG and MDA contents (P < 0.05, P < 0.01), but increased liver glutathione (GSH) content (P < 0.01). TBA content was significantly lower in the high-dose hydrolysate group (P < 0.05). The hydrolysate at high and low doses alleviated alcohol-induced liver damage in mice, and significantly down-regulated the mRNA transcription levels of the genes encoding toll-like recepror 4 (TLR4), tumor necrosis factor α (TNF-α), and nuclear factor-kappa B (NF-κB) (P < 0.05). The hydrolysate increased the abundance of Firmicutes as well as Lactobacillus and Alistipes, and reduced the abundance of Bacteroidetes in the gut of mice. In conclusion, the enzymatic hydrolysate can protect against chronic alcoholic liver injury in mice through reducing the activity of AST and ALT, and the contents of TG, MDA and TBA, increasing GSH content, down-regulating the mRNA transcription levels of TLR4, NF-κB and TNF-α, and changing the structure of the gut microflora.

Key words: oyster enzymatic hydrolysate; chronic alcoholic liver injury; hepatoprotective effect; intestinal microflora

中图分类号: